Improvement of Endothelial Function With Dietary Flavanols Is Associated With Mobilization of Circulating Angiogenic Cells in Patients With Coronary Artery Disease
Objectives In patients with coronary artery disease (CAD) medically managed according to currently accepted guidelines, we tested whether a 1-month dietary intervention with flavanol-containing cocoa leads to an improvement of endothelial dysfunction and whether this is associated with an enhanced n...
Saved in:
Published in: | Journal of the American College of Cardiology Vol. 56; no. 3; pp. 218 - 224 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
New York, NY
Elsevier Inc
13-07-2010
Elsevier Elsevier Limited |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Objectives In patients with coronary artery disease (CAD) medically managed according to currently accepted guidelines, we tested whether a 1-month dietary intervention with flavanol-containing cocoa leads to an improvement of endothelial dysfunction and whether this is associated with an enhanced number and function of circulating angiogenic cells (CACs). Background Dietary flavanols can improve endothelial dysfunction. The CACs, also termed endothelial progenitor cells, are critical for vascular repair and maintenance of endothelial function. Methods In a randomized, controlled, double-masked, cross-over trial, 16 CAD patients (64 ± 3 years of age) received a dietary high-flavanol intervention (HiFI [375 mg]) and a macronutrient- and micronutrient-matched low-flavanol intervention (LoFI [9 mg]) twice daily in random order over 30 days. Results Endothelium-dependent vasomotor function, as measured by flow-mediated vasodilation of the brachial artery, improved by 47% in the HiFI period compared with the LoFI period. After HiFI, the number of CD34+ /KDR+ -CACs, as measured by flow cytometry, increased 2.2-fold as compared with after LoFI. The CAC functions, as measured by the capacity to survive, differentiate, proliferate, and to migrate were not different between the groups. The HiFI led to a decrease in systolic blood pressure (mean change over LoFI: −4.2 ± 2.7 mm Hg), and increase in plasma nitrite level (mean change over LoFI: 74 ± 32 nM). Applying a mixed-effects linear regression model, the results demonstrated a significant increase in flow-mediated vasodilation and a decrease in systolic blood pressure with increasing levels of CD34+ /KDR+ -CACs. Conclusions Sustained improvements in endothelial dysfunction by regular dietary intake of flavanols are associated with mobilization of functional CACs. (Effect of Cocoa Flavanols on Vascular Function in Optimally Treated Coronary Artery Disease Patients: Interaction Between Endothelial Progenitor Cells, Reactivity of Micro- and Macrocirculation; NCT00553774 ). |
---|---|
AbstractList | Objectives In patients with coronary artery disease (CAD) medically managed according to currently accepted guidelines, we tested whether a 1-month dietary intervention with flavanol-containing cocoa leads to an improvement of endothelial dysfunction and whether this is associated with an enhanced number and function of circulating angiogenic cells (CACs). Background Dietary flavanols can improve endothelial dysfunction. The CACs, also termed endothelial progenitor cells, are critical for vascular repair and maintenance of endothelial function. Methods In a randomized, controlled, double-masked, cross-over trial, 16 CAD patients (64 ± 3 years of age) received a dietary high-flavanol intervention (HiFI [375 mg]) and a macronutrient- and micronutrient-matched low-flavanol intervention (LoFI [9 mg]) twice daily in random order over 30 days. Results Endothelium-dependent vasomotor function, as measured by flow-mediated vasodilation of the brachial artery, improved by 47% in the HiFI period compared with the LoFI period. After HiFI, the number of CD34+ /KDR+ -CACs, as measured by flow cytometry, increased 2.2-fold as compared with after LoFI. The CAC functions, as measured by the capacity to survive, differentiate, proliferate, and to migrate were not different between the groups. The HiFI led to a decrease in systolic blood pressure (mean change over LoFI: −4.2 ± 2.7 mm Hg), and increase in plasma nitrite level (mean change over LoFI: 74 ± 32 nM). Applying a mixed-effects linear regression model, the results demonstrated a significant increase in flow-mediated vasodilation and a decrease in systolic blood pressure with increasing levels of CD34+ /KDR+ -CACs. Conclusions Sustained improvements in endothelial dysfunction by regular dietary intake of flavanols are associated with mobilization of functional CACs. (Effect of Cocoa Flavanols on Vascular Function in Optimally Treated Coronary Artery Disease Patients: Interaction Between Endothelial Progenitor Cells, Reactivity of Micro- and Macrocirculation; NCT00553774 ). OBJECTIVESIn patients with coronary artery disease (CAD) medically managed according to currently accepted guidelines, we tested whether a 1-month dietary intervention with flavanol-containing cocoa leads to an improvement of endothelial dysfunction and whether this is associated with an enhanced number and function of circulating angiogenic cells (CACs).BACKGROUNDDietary flavanols can improve endothelial dysfunction. The CACs, also termed endothelial progenitor cells, are critical for vascular repair and maintenance of endothelial function.METHODSIn a randomized, controlled, double-masked, cross-over trial, 16 CAD patients (64+/-3 years of age) received a dietary high-flavanol intervention (HiFI [375 mg]) and a macronutrient- and micronutrient-matched low-flavanol intervention (LoFI [9 mg]) twice daily in random order over 30 days.RESULTSEndothelium-dependent vasomotor function, as measured by flow-mediated vasodilation of the brachial artery, improved by 47% in the HiFI period compared with the LoFI period. After HiFI, the number of CD34+/KDR+-CACs, as measured by flow cytometry, increased 2.2-fold as compared with after LoFI. The CAC functions, as measured by the capacity to survive, differentiate, proliferate, and to migrate were not different between the groups. The HiFI led to a decrease in systolic blood pressure (mean change over LoFI: -4.2+/-2.7 mm Hg), and increase in plasma nitrite level (mean change over LoFI: 74+/-32 nM). Applying a mixed-effects linear regression model, the results demonstrated a significant increase in flow-mediated vasodilation and a decrease in systolic blood pressure with increasing levels of CD34+/KDR+-CACs.CONCLUSIONSSustained improvements in endothelial dysfunction by regular dietary intake of flavanols are associated with mobilization of functional CACs. (Effect of Cocoa Flavanols on Vascular Function in Optimally Treated Coronary Artery Disease Patients: Interaction Between Endothelial Progenitor Cells, Reactivity of Micro- and Macrocirculation; NCT00553774). In patients with coronary artery disease (CAD) medically managed according to currently accepted guidelines, we tested whether a 1-month dietary intervention with flavanol-containing cocoa leads to an improvement of endothelial dysfunction and whether this is associated with an enhanced number and function of circulating angiogenic cells (CACs). Dietary flavanols can improve endothelial dysfunction. The CACs, also termed endothelial progenitor cells, are critical for vascular repair and maintenance of endothelial function. In a randomized, controlled, double-masked, cross-over trial, 16 CAD patients (64+/-3 years of age) received a dietary high-flavanol intervention (HiFI [375 mg]) and a macronutrient- and micronutrient-matched low-flavanol intervention (LoFI [9 mg]) twice daily in random order over 30 days. Endothelium-dependent vasomotor function, as measured by flow-mediated vasodilation of the brachial artery, improved by 47% in the HiFI period compared with the LoFI period. After HiFI, the number of CD34+/KDR+-CACs, as measured by flow cytometry, increased 2.2-fold as compared with after LoFI. The CAC functions, as measured by the capacity to survive, differentiate, proliferate, and to migrate were not different between the groups. The HiFI led to a decrease in systolic blood pressure (mean change over LoFI: -4.2+/-2.7 mm Hg), and increase in plasma nitrite level (mean change over LoFI: 74+/-32 nM). Applying a mixed-effects linear regression model, the results demonstrated a significant increase in flow-mediated vasodilation and a decrease in systolic blood pressure with increasing levels of CD34+/KDR+-CACs. Sustained improvements in endothelial dysfunction by regular dietary intake of flavanols are associated with mobilization of functional CACs. (Effect of Cocoa Flavanols on Vascular Function in Optimally Treated Coronary Artery Disease Patients: Interaction Between Endothelial Progenitor Cells, Reactivity of Micro- and Macrocirculation; NCT00553774). In patients with coronary artery disease (CAD) medically managed according to currently accepted guidelines, we tested whether a 1-month dietary intervention with flavanol-containing cocoa leads to an improvement of endothelial dysfunction and whether this is associated with an enhanced number and function of circulating angiogenic cells (CACs). Dietary flavanols can improve endothelial dysfunction. The CACs, also termed endothelial progenitor cells, are critical for vascular repair and maintenance of endothelial function. In a randomized, controlled, double-masked, cross-over trial, 16 CAD patients (64 ± 3 years of age) received a dietary high-flavanol intervention (HiFI [375 mg]) and a macronutrient- and micronutrient-matched low-flavanol intervention (LoFI [9 mg]) twice daily in random order over 30 days. Endothelium-dependent vasomotor function, as measured by flow-mediated vasodilation of the brachial artery, improved by 47% in the HiFI period compared with the LoFI period. After HiFI, the number of CD34+/KDR+-CACs, as measured by flow cytometry, increased 2.2-fold as compared with after LoFI. The CAC functions, as measured by the capacity to survive, differentiate, proliferate, and to migrate were not different between the groups. The HiFI led to a decrease in systolic blood pressure (mean change over LoFI: −4.2 ± 2.7 mm Hg), and increase in plasma nitrite level (mean change over LoFI: 74 ± 32 nM). Applying a mixed-effects linear regression model, the results demonstrated a significant increase in flow-mediated vasodilation and a decrease in systolic blood pressure with increasing levels of CD34+/KDR+-CACs. Sustained improvements in endothelial dysfunction by regular dietary intake of flavanols are associated with mobilization of functional CACs. (Effect of Cocoa Flavanols on Vascular Function in Optimally Treated Coronary Artery Disease Patients: Interaction Between Endothelial Progenitor Cells, Reactivity of Micro- and Macrocirculation; NCT00553774). Objectives In patients with coronary artery disease (CAD) medically managed according to currently accepted guidelines, we tested whether a 1-month dietary intervention with flavanol-containing cocoa leads to an improvement of endothelial dysfunction and whether this is associated with an enhanced number and function of circulating angiogenic cells (CACs). Background Dietary flavanols can improve endothelial dysfunction. The CACs, also termed endothelial progenitor cells, are critical for vascular repair and maintenance of endothelial function. Methods In a randomized, controlled, double-masked, cross-over trial, 16 CAD patients (64 ± 3 years of age) received a dietary high-flavanol intervention (HiFI [375 mg]) and a macronutrient- and micronutrient-matched low-flavanol intervention (LoFI [9 mg]) twice daily in random order over 30 days. Results Endothelium-dependent vasomotor function, as measured by flow-mediated vasodilation of the brachial artery, improved by 47% in the HiFI period compared with the LoFI period. After HiFI, the number of CD34+/KDR+-CACs, as measured by flow cytometry, increased 2.2-fold as compared with after LoFI. The CAC functions, as measured by the capacity to survive, differentiate, proliferate, and to migrate were not different between the groups. The HiFI led to a decrease in systolic blood pressure (mean change over LoFI: -4.2 ± 2.7 mm Hg), and increase in plasma nitrite level (mean change over LoFI: 74 ± 32 nM). Applying a mixed-effects linear regression model, the results demonstrated a significant increase in flow-mediated vasodilation and a decrease in systolic blood pressure with increasing levels of CD34+/KDR+-CACs. Conclusions Sustained improvements in endothelial dysfunction by regular dietary intake of flavanols are associated with mobilization of functional CACs. (Effect of Cocoa Flavanols on Vascular Function in Optimally Treated Coronary Artery Disease Patients: Interaction Between Endothelial Progenitor Cells, Reactivity of Micro- and Macrocirculation;NCT00553774). |
Author | Glantz, Stanton A., PhD Springer, Matthew L., PhD Real, Wendy May, BS Yeghiazarians, Yerem, MD Mihardja, Shirley, PhD Heiss, Christian, MD, DrMed Wong, Maelene L., BS Ottaviani, Javier I., PhD Angeli, Franca S., MD Keen, Carl L., PhD Schroeter, Hagen, PhD Boyle, Andrew, MBBS, PhD Prasad, Megha, BA Jahn, Sarah, MB Grossman, William, MD Taylor, Melanie, BS Amabile, Nicolas, MD Rassaf, Tienush, MD, DrMed |
Author_xml | – sequence: 1 fullname: Heiss, Christian, MD, DrMed – sequence: 2 fullname: Jahn, Sarah, MB – sequence: 3 fullname: Taylor, Melanie, BS – sequence: 4 fullname: Real, Wendy May, BS – sequence: 5 fullname: Angeli, Franca S., MD – sequence: 6 fullname: Wong, Maelene L., BS – sequence: 7 fullname: Amabile, Nicolas, MD – sequence: 8 fullname: Prasad, Megha, BA – sequence: 9 fullname: Rassaf, Tienush, MD, DrMed – sequence: 10 fullname: Ottaviani, Javier I., PhD – sequence: 11 fullname: Mihardja, Shirley, PhD – sequence: 12 fullname: Keen, Carl L., PhD – sequence: 13 fullname: Springer, Matthew L., PhD – sequence: 14 fullname: Boyle, Andrew, MBBS, PhD – sequence: 15 fullname: Grossman, William, MD – sequence: 16 fullname: Glantz, Stanton A., PhD – sequence: 17 fullname: Schroeter, Hagen, PhD – sequence: 18 fullname: Yeghiazarians, Yerem, MD |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=23038813$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/20620742$$D View this record in MEDLINE/PubMed |
BookMark | eNp9klFrFDEQxxep2Gv1C_ggCyI-3TnZ7G4SkMKx7elBRUHFx5DNzl5z5pKa7B7Ur-MXNeudFvogBIYkv_9kMv85y06cd5hlzwksCJD6zXaxVVovCkgHQNMSj7IZqSo-p5VgJ9kMGK3mBAQ7zc5i3AJAzYl4kp0WUBfAymKW_VrvboPf4w7dkPs-v3KdH27QGmXz1ej0YLzLv5nhJr80OKhwl6-s2ivnbczXMV_G6LVRA3YH6INvjTU_1R9ZSteYoEebtm6TL93G-A06o_MGbdIbl39KV-nleFA3Png3vbEMA6ZwaSKqiE-zx72yEZ8d43n2dXX1pXk_v_74bt0sr-e6IsUwV0UtAAqCFeNckbZtQdStYAiq7bpekF71lHHRdjXhhEPPVYm8LDgjvATW0fPs9SFv6siPEeMgdybqVKpy6McoGaWCl1UhEvnyAbn1Y3CpOEmq1FsGrC4TVRwoHXyMAXt5G8wu_U8SkJODcisnB-XkoASa1pT6xTH12O6w-yf5a1kCXh0BFbWyfVBOm3jPUaCcE5q4twcOU8v2BoOMOvVaY2cC6kF23vy_josHcm1N8k7Z73iH8f6_MhYS5Odp1qZRIwCE0bqivwHNEdFf |
CODEN | JACCDI |
CitedBy_id | crossref_primary_10_1080_07315724_2018_1451788 crossref_primary_10_1016_j_freeradbiomed_2011_12_010 crossref_primary_10_1111_jch_12715 crossref_primary_10_1089_ars_2014_6158 crossref_primary_10_1089_jmf_2018_0209 crossref_primary_10_1017_S0007114516002348 crossref_primary_10_3945_jn_111_152470 crossref_primary_10_1016_j_jff_2016_03_024 crossref_primary_10_1161_HYPERTENSIONAHA_110_158139 crossref_primary_10_3390_jcdd11060174 crossref_primary_10_52711_0974_360X_2023_00052 crossref_primary_10_1017_S0007114515002822 crossref_primary_10_1152_ajpcell_00406_2010 crossref_primary_10_3390_nu16010041 crossref_primary_10_1016_j_freeradbiomed_2014_12_009 crossref_primary_10_1177_0003319718774660 crossref_primary_10_1007_s11357_015_9794_9 crossref_primary_10_1177_1934578X1501001118 crossref_primary_10_1093_eurheartj_ehq332 crossref_primary_10_3390_nu13041103 crossref_primary_10_3945_ajcn_111_023457 crossref_primary_10_1002_ptr_5665 crossref_primary_10_3945_ajcn_111_028340 crossref_primary_10_1016_j_abb_2012_02_021 crossref_primary_10_1039_C4FO00570H crossref_primary_10_3389_fcvm_2021_632131 crossref_primary_10_3390_antiox8120650 crossref_primary_10_1161_CIRCULATIONAHA_112_112912 crossref_primary_10_1161_JAHA_114_001472 crossref_primary_10_1111_j_1467_3010_2012_01984_x crossref_primary_10_1051_bioconf_20236804004 crossref_primary_10_3390_biomedicines11113051 crossref_primary_10_1007_s11906_012_0281_8 crossref_primary_10_2174_1570159X21666221031103909 crossref_primary_10_3390_nu12041098 crossref_primary_10_3390_nu10080986 crossref_primary_10_1016_j_atherosclerosis_2018_04_012 crossref_primary_10_1016_j_tetlet_2012_01_054 crossref_primary_10_1089_ars_2012_4581 crossref_primary_10_1093_ajcn_nqy066 crossref_primary_10_1016_j_dib_2018_04_149 crossref_primary_10_1080_21551197_2012_702541 crossref_primary_10_1016_j_vph_2015_02_010 crossref_primary_10_1016_j_redox_2013_12_015 crossref_primary_10_1021_acs_jafc_5b01064 crossref_primary_10_1093_ajcn_nqy229 crossref_primary_10_1038_s41598_020_74863_7 crossref_primary_10_1152_japplphysiol_01302_2012 crossref_primary_10_1038_srep29034 crossref_primary_10_1039_C8FO00483H crossref_primary_10_1017_S0007114513003693 crossref_primary_10_3390_molecules24234295 crossref_primary_10_3390_antiox8040088 crossref_primary_10_3945_ajcn_113_066639 crossref_primary_10_1007_s12170_011_0157_5 crossref_primary_10_3945_ajcn_113_071274 crossref_primary_10_1017_S0007114516004219 crossref_primary_10_1177_1074248416639719 crossref_primary_10_1016_j_foodchem_2014_06_107 crossref_primary_10_1007_s13668_013_0058_y crossref_primary_10_1007_s10298_013_0764_z crossref_primary_10_3390_ijms23010183 crossref_primary_10_1017_S0007114512000475 crossref_primary_10_1016_j_freeradbiomed_2012_02_051 crossref_primary_10_1152_ajplung_00215_2010 crossref_primary_10_1016_j_mam_2010_09_008 crossref_primary_10_3945_jn_111_145482 crossref_primary_10_3389_fimmu_2017_00677 crossref_primary_10_3945_ajcn_110_000075 crossref_primary_10_3945_ajcn_111_029330 crossref_primary_10_3390_diseases4040039 crossref_primary_10_1016_j_mam_2017_12_001 crossref_primary_10_1016_j_ijcard_2011_06_091 crossref_primary_10_1089_ars_2010_3697 crossref_primary_10_15446_rfnam_v68n1_47836 crossref_primary_10_3390_nu13051646 crossref_primary_10_3945_ajcn_115_116178 crossref_primary_10_1002_mnfr_201200595 crossref_primary_10_1039_D3FO01116J crossref_primary_10_3390_nu7075177 crossref_primary_10_1093_cvr_cvac095 crossref_primary_10_1161_HYPERTENSIONAHA_112_193060 crossref_primary_10_1016_j_mvr_2018_10_008 crossref_primary_10_1177_2047487318800072 crossref_primary_10_1373_clinchem_2011_167361 crossref_primary_10_1016_j_heliyon_2024_e24430 crossref_primary_10_1016_j_maturitas_2011_05_011 crossref_primary_10_1016_j_atherosclerosis_2012_06_007 crossref_primary_10_3390_nu8060321 crossref_primary_10_1017_S0954422417000105 crossref_primary_10_1016_j_advnut_2023_01_002 crossref_primary_10_1002_ehf2_12077 crossref_primary_10_1590_1981_6723_19416 crossref_primary_10_3390_nu7125519 crossref_primary_10_1080_1028415X_2023_2298098 crossref_primary_10_1007_s11883_011_0203_2 crossref_primary_10_1016_j_clnme_2013_02_003 crossref_primary_10_1017_S0954422413000036 crossref_primary_10_1007_s12263_011_0255_5 crossref_primary_10_1021_acs_jafc_2c04519 crossref_primary_10_1017_S0954422420000049 crossref_primary_10_1152_japplphysiol_00865_2011 crossref_primary_10_3389_fnut_2017_00036 crossref_primary_10_3945_ajcn_116_140046 crossref_primary_10_1016_j_clnu_2020_06_039 crossref_primary_10_1038_leu_2011_184 crossref_primary_10_1002_mnfr_201600045 crossref_primary_10_1016_j_healun_2015_03_004 crossref_primary_10_1093_jn_nxy005 crossref_primary_10_2215_CJN_05560515 crossref_primary_10_1016_j_nut_2010_10_013 crossref_primary_10_1017_S0007114514003353 crossref_primary_10_1039_D1FO02369A crossref_primary_10_1016_j_abb_2014_03_014 crossref_primary_10_1080_10408398_2023_2248506 crossref_primary_10_2903_j_efsa_2012_2809 crossref_primary_10_5567_pharmacologia_2015_21_30 crossref_primary_10_1016_j_tetasy_2013_02_012 crossref_primary_10_3390_ijms22094665 crossref_primary_10_1017_S0007114511002996 crossref_primary_10_1002_14651858_CD008893_pub3 crossref_primary_10_1016_j_clnesp_2019_10_017 crossref_primary_10_1016_j_fct_2012_05_013 crossref_primary_10_1016_j_freeradbiomed_2011_09_010 crossref_primary_10_1016_j_abb_2018_03_004 crossref_primary_10_1016_j_phanu_2016_05_002 crossref_primary_10_1016_j_ijcard_2012_10_047 crossref_primary_10_1002_mnfr_202100991 crossref_primary_10_1007_s00394_012_0334_4 crossref_primary_10_1016_j_jff_2012_09_002 crossref_primary_10_1089_ars_2019_7922 crossref_primary_10_1016_j_niox_2012_05_003 crossref_primary_10_1039_D3FO01737K crossref_primary_10_3109_07853890_2010_543920 crossref_primary_10_1139_apnm_2015_0543 crossref_primary_10_1021_np300568m crossref_primary_10_1097_FJC_0b013e318269ae0d crossref_primary_10_1146_annurev_nutr_071811_150642 crossref_primary_10_1039_C9FO01747J crossref_primary_10_1016_j_mam_2017_10_003 |
Cites_doi | 10.1073/pnas.0510168103 10.1038/nchembio.260 10.1016/j.jacc.2006.09.050 10.1161/CIRCULATIONAHA.108.827022 10.1093/ajcn/81.1.317S 10.1007/s00109-004-0580-x 10.1016/j.jacc.2004.12.074 10.1056/NEJMoa043814 10.1016/j.jacc.2006.04.026 10.1097/FJC.0b013e31802d0001 10.1016/j.jacc.2008.01.059 |
ContentType | Journal Article |
Copyright | American College of Cardiology Foundation 2010 American College of Cardiology Foundation 2015 INIST-CNRS Copyright (c) 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. Copyright Elsevier Limited Jul 13, 2010 |
Copyright_xml | – notice: American College of Cardiology Foundation – notice: 2010 American College of Cardiology Foundation – notice: 2015 INIST-CNRS – notice: Copyright (c) 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. – notice: Copyright Elsevier Limited Jul 13, 2010 |
DBID | 6I. AAFTH IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7T5 7TK H94 K9. NAPCQ 7X8 |
DOI | 10.1016/j.jacc.2010.03.039 |
DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Immunology Abstracts Neurosciences Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium Immunology Abstracts Neurosciences Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE AIDS and Cancer Research Abstracts |
Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1558-3597 |
EndPage | 224 |
ExternalDocumentID | 3243094561 10_1016_j_jacc_2010_03_039 20620742 23038813 S0735109710017365 1_s2_0_S0735109710017365 |
Genre | Randomized Controlled Trial Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: N30 Pharmaceuticals – fundername: American Heart Association – fundername: Mars, Inc. – fundername: Mars Inc. |
GroupedDBID | --- --K --M .1- .55 .FO .GJ .~1 0R~ 0SF 18M 1B1 1CY 1P~ 1~. 1~5 29L 2WC 3O- 3V. 4.4 457 4G. 53G 5GY 5RE 5VS 6I. 6PF 7-5 71M 7RV 8P~ AABNK AABVL AACTN AAEDT AAEDW AAFTH AAIKJ AAKUH AALRI AAOAW AAQFI AAQQT AAQXK AAXUO AAYOK ABBQC ABFNM ABFRF ABJNI ABLJU ABMAC ABMZM ABOCM ABVKL ABXDB ACGFO ACGFS ACIUM ACJTP ACPRK ADBBV ADEZE ADMUD ADVLN AEFWE AEKER AENEX AEVXI AEXQZ AFCTW AFETI AFFNX AFRAH AFRHN AFTJW AGHFR AGYEJ AHMBA AITUG AJOXV AJRQY AKRWK ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ASPBG AVWKF AZFZN BAWUL BENPR BLXMC BPHCQ CS3 DIK DU5 E3Z EBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FNPLU G-Q GBLVA GX1 H13 HVGLF HX~ HZ~ IHE IXB J1W J5H K-O KQ8 L7B MO0 N4W N9A NCXOZ O-L O9- OA. OAUVE OK1 OL~ OZT P-8 P-9 P2P PC. PQQKQ PROAC Q38 QTD R2- RIG ROL RPZ SCC SDF SDG SDP SES SEW SSZ T5K TR2 UNMZH UV1 W8F WH7 WOQ WOW X7M XPP YYM YYP YZZ Z5R ZGI ZXP AAIAV EFLBG LCYCR NAHTW ZA5 08R AAUGY AKALU IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7T5 7TK H94 K9. NAPCQ 7X8 |
ID | FETCH-LOGICAL-c512t-a2690021e5788a1bbb096b97e0abddf91faf3789bd618180f8a4e8428718407d3 |
ISSN | 0735-1097 |
IngestDate | Fri Oct 25 04:01:44 EDT 2024 Thu Oct 10 22:44:47 EDT 2024 Thu Sep 12 17:31:03 EDT 2024 Tue Oct 15 23:38:20 EDT 2024 Sun Oct 22 16:02:09 EDT 2023 Fri Feb 23 02:26:31 EST 2024 Tue Oct 15 22:53:22 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | coronary artery disease NO LoFI HiFI flow-mediated vasodilation angiogenic cells SDF high-flavanol intervention LDL FMD nitric oxide stem cell factor CAC VEGF CAD flavanols stromal cell-derived factor low-density lipoprotein circulating angiogenic cell brachial artery nutrition vascular endothelial growth factor low-flavanol intervention SCF flow-mediated dilation BA Human Mobilization Improvement Diet therapy Diet Cardiovascular disease Patient Circulatory system Endothelial function Cardiology Coronary heart disease Cell |
Language | English |
License | http://www.elsevier.com/open-access/userlicense/1.0 CC BY 4.0 Copyright (c) 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c512t-a2690021e5788a1bbb096b97e0abddf91faf3789bd618180f8a4e8428718407d3 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-News-1 ObjectType-Feature-3 content type line 23 |
OpenAccessLink | https://dx.doi.org/10.1016/j.jacc.2010.03.039 |
PMID | 20620742 |
PQID | 1506270764 |
PQPubID | 2031078 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_733984529 proquest_journals_1506270764 crossref_primary_10_1016_j_jacc_2010_03_039 pubmed_primary_20620742 pascalfrancis_primary_23038813 elsevier_sciencedirect_doi_10_1016_j_jacc_2010_03_039 elsevier_clinicalkeyesjournals_1_s2_0_S0735109710017365 |
PublicationCentury | 2000 |
PublicationDate | 2010-07-13 |
PublicationDateYYYYMMDD | 2010-07-13 |
PublicationDate_xml | – month: 07 year: 2010 text: 2010-07-13 day: 13 |
PublicationDecade | 2010 |
PublicationPlace | New York, NY |
PublicationPlace_xml | – name: New York, NY – name: United States – name: New York |
PublicationTitle | Journal of the American College of Cardiology |
PublicationTitleAlternate | J Am Coll Cardiol |
PublicationYear | 2010 |
Publisher | Elsevier Inc Elsevier Elsevier Limited |
Publisher_xml | – name: Elsevier Inc – name: Elsevier – name: Elsevier Limited |
References | Shantsila, Watson, Lip (bib5) 2007; 49 Lundberg, Gladwin, Ahluwalia (bib10) 2009; 5 Smith, Allen, Blair (bib6) 2006; 47 Corti, Flammer, Hollenberg, Luscher (bib2) 2009; 119 Dimmeler, Zeiher (bib4) 2004; 82 Heiss, Keymel, Niesler, Ziemann, Kelm, Kalka (bib8) 2005; 45 Heiss, Finis, Kleinbongard (bib9) 2007; 49 Arts, Hollman (bib1) 2005 Balzer, Rassaf, Heiss (bib11) 2008; 51 Werner, Kosiol, Schiegl (bib3) 2005; 353 Schroeter, Heiss, Balzer (bib7) 2006; 103 Dimmeler (10.1016/j.jacc.2010.03.039_bib4) 2004; 82 Shantsila (10.1016/j.jacc.2010.03.039_bib5) 2007; 49 Heiss (10.1016/j.jacc.2010.03.039_bib8) 2005; 45 Arts (10.1016/j.jacc.2010.03.039_bib1) 2005 Werner (10.1016/j.jacc.2010.03.039_bib3) 2005; 353 Smith (10.1016/j.jacc.2010.03.039_bib6) 2006; 47 Schroeter (10.1016/j.jacc.2010.03.039_bib7) 2006; 103 Heiss (10.1016/j.jacc.2010.03.039_bib9) 2007; 49 Balzer (10.1016/j.jacc.2010.03.039_bib11) 2008; 51 Lundberg (10.1016/j.jacc.2010.03.039_bib10) 2009; 5 Corti (10.1016/j.jacc.2010.03.039_bib2) 2009; 119 |
References_xml | – volume: 47 start-page: 2130 year: 2006 end-page: 2139 ident: bib6 article-title: AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update publication-title: J Am Coll Cardiol contributor: fullname: Blair – volume: 49 start-page: 741 year: 2007 end-page: 752 ident: bib5 article-title: Endothelial progenitor cells in cardiovascular disorders publication-title: J Am Coll Cardiol contributor: fullname: Lip – volume: 82 start-page: 671 year: 2004 end-page: 677 ident: bib4 article-title: Vascular repair by circulating endothelial progenitor cells: the missing link in atherosclerosis? publication-title: J Mol Med contributor: fullname: Zeiher – volume: 45 start-page: 1441 year: 2005 end-page: 1448 ident: bib8 article-title: Impaired progenitor cell activity in age-related endothelial dysfunction publication-title: J Am Coll Cardiol contributor: fullname: Kalka – volume: 103 start-page: 1024 year: 2006 end-page: 1029 ident: bib7 article-title: (−)-epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans publication-title: Proc Natl Acad Sci U S A contributor: fullname: Balzer – volume: 49 start-page: 74 year: 2007 end-page: 80 ident: bib9 article-title: Sustained increase in flow-mediated dilation after daily intake of high-flavanol cocoa drink over 1 week publication-title: J Cardiovasc Pharmacol contributor: fullname: Kleinbongard – volume: 5 start-page: 865 year: 2009 end-page: 869 ident: bib10 article-title: Nitrate and nitrite in biology, nutrition and therapeutics publication-title: Nat Chem Biol contributor: fullname: Ahluwalia – volume: 353 start-page: 999 year: 2005 end-page: 1007 ident: bib3 article-title: Circulating endothelial progenitor cells and cardiovascular outcomes publication-title: N Engl J Med contributor: fullname: Schiegl – start-page: 317 year: 2005 end-page: 325 ident: bib1 article-title: Polyphenols and disease risk in epidemiologic studies publication-title: Am J Clin Nutr contributor: fullname: Hollman – volume: 119 start-page: 1433 year: 2009 end-page: 1441 ident: bib2 article-title: Cocoa and cardiovascular health publication-title: Circulation contributor: fullname: Luscher – volume: 51 start-page: 2141 year: 2008 end-page: 2149 ident: bib11 article-title: Sustained benefits in vascular function through flavanol-containing cocoa in medicated diabetic patients a double-masked, randomized, controlled trial publication-title: J Am Coll Cardiol contributor: fullname: Heiss – volume: 103 start-page: 1024 year: 2006 ident: 10.1016/j.jacc.2010.03.039_bib7 article-title: (−)-epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.0510168103 contributor: fullname: Schroeter – volume: 5 start-page: 865 year: 2009 ident: 10.1016/j.jacc.2010.03.039_bib10 article-title: Nitrate and nitrite in biology, nutrition and therapeutics publication-title: Nat Chem Biol doi: 10.1038/nchembio.260 contributor: fullname: Lundberg – volume: 49 start-page: 741 year: 2007 ident: 10.1016/j.jacc.2010.03.039_bib5 article-title: Endothelial progenitor cells in cardiovascular disorders publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2006.09.050 contributor: fullname: Shantsila – volume: 119 start-page: 1433 year: 2009 ident: 10.1016/j.jacc.2010.03.039_bib2 article-title: Cocoa and cardiovascular health publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.108.827022 contributor: fullname: Corti – start-page: 317 issue: 81 Suppl year: 2005 ident: 10.1016/j.jacc.2010.03.039_bib1 article-title: Polyphenols and disease risk in epidemiologic studies publication-title: Am J Clin Nutr doi: 10.1093/ajcn/81.1.317S contributor: fullname: Arts – volume: 82 start-page: 671 year: 2004 ident: 10.1016/j.jacc.2010.03.039_bib4 article-title: Vascular repair by circulating endothelial progenitor cells: the missing link in atherosclerosis? publication-title: J Mol Med doi: 10.1007/s00109-004-0580-x contributor: fullname: Dimmeler – volume: 45 start-page: 1441 year: 2005 ident: 10.1016/j.jacc.2010.03.039_bib8 article-title: Impaired progenitor cell activity in age-related endothelial dysfunction publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2004.12.074 contributor: fullname: Heiss – volume: 353 start-page: 999 year: 2005 ident: 10.1016/j.jacc.2010.03.039_bib3 article-title: Circulating endothelial progenitor cells and cardiovascular outcomes publication-title: N Engl J Med doi: 10.1056/NEJMoa043814 contributor: fullname: Werner – volume: 47 start-page: 2130 year: 2006 ident: 10.1016/j.jacc.2010.03.039_bib6 article-title: AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2006.04.026 contributor: fullname: Smith – volume: 49 start-page: 74 year: 2007 ident: 10.1016/j.jacc.2010.03.039_bib9 article-title: Sustained increase in flow-mediated dilation after daily intake of high-flavanol cocoa drink over 1 week publication-title: J Cardiovasc Pharmacol doi: 10.1097/FJC.0b013e31802d0001 contributor: fullname: Heiss – volume: 51 start-page: 2141 year: 2008 ident: 10.1016/j.jacc.2010.03.039_bib11 article-title: Sustained benefits in vascular function through flavanol-containing cocoa in medicated diabetic patients a double-masked, randomized, controlled trial publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2008.01.059 contributor: fullname: Balzer |
SSID | ssj0006819 |
Score | 2.4690263 |
Snippet | Objectives In patients with coronary artery disease (CAD) medically managed according to currently accepted guidelines, we tested whether a 1-month dietary... In patients with coronary artery disease (CAD) medically managed according to currently accepted guidelines, we tested whether a 1-month dietary intervention... OBJECTIVESIn patients with coronary artery disease (CAD) medically managed according to currently accepted guidelines, we tested whether a 1-month dietary... |
SourceID | proquest crossref pubmed pascalfrancis elsevier |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 218 |
SubjectTerms | angiogenic cells Bioavailability Biological and medical sciences Blood Pressure Cacao Cardiology Cardiology. Vascular system Cardiovascular Cardiovascular disease Cholesterol coronary artery disease Coronary Disease - diet therapy Coronary Disease - physiopathology Coronary heart disease Diet Diseases of the digestive system Double-Blind Method Drug therapy Endothelial Cells - physiology Endothelium, Vascular - drug effects Endothelium, Vascular - physiology Enzymes Female flavanols Flavonoids - administration & dosage Flavonoids - pharmacology Flow velocity flow-mediated vasodilation Heart Heart rate Humans Internal Medicine Intervention Lipoproteins Male Medical sciences Middle Aged Mortality Neovascularization, Physiologic - physiology nutrition Plasma Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects) Statins Studies Variance analysis Vascular endothelial growth factor Vasodilation - physiology |
Title | Improvement of Endothelial Function With Dietary Flavanols Is Associated With Mobilization of Circulating Angiogenic Cells in Patients With Coronary Artery Disease |
URI | https://www.clinicalkey.es/playcontent/1-s2.0-S0735109710017365 https://dx.doi.org/10.1016/j.jacc.2010.03.039 https://www.ncbi.nlm.nih.gov/pubmed/20620742 https://www.proquest.com/docview/1506270764 https://search.proquest.com/docview/733984529 |
Volume | 56 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3da9swEBdpB2Mwxr7nrSt62FtwSazYlh9LmpAOMsba0bEX4Q-5czB2qZOH9t_pP7o7SZadhY5tMDAmUSxb4X6-O51-dyLkQ5CwKJV-4E5YCidwGVwe-JHr-bGfp6D-Qo65w4uz8NM3fjKbzAaDdt_Rru2_ShraQNaYOfsX0rY3hQb4DDKHM0gdzn8kdx0lkO0a_6zKMMeqxMD4HGyYEvcFBl9PCrlGyty8jMGbrstmeNpYaYEbqi5a1kievbV-5bS4TtWGXxhMqS6LGsZRpMOpLEtFrP2sy7Q2uvcUyyPgM46ROHqDpT7tatCuQ9xLcqn6AY2posz2o_8LWTS90gg9hH-Mf1Q7ge4uKrGUJabU21UmqbY7GF7IKrsZLg2fyMRAcPk-dHUKqw7Mtck5W9xRUF5YZFXTf4-k0e8-d5lv2owB0JXNDdDZljbnPcfA08neOzZHhz9WR6s4TQ1XkMERdRbW8h7PcEw4JKx8FbLA3yMPPNCQqKC_-1-sCxFwtSON_Qcm20sTE399zn0e1eOruIH3PNcbtNw_g1Ke1PlT8sRInB5r7D4jA1k9Jw-XhuTxgtz1IEzrnPYgTFsIU8QXNRCmFsL0tKEdhPVFfQjj7XoQph2EqYIwLSraQlj3biFMNYSpgfBL8nU-O58uXLOXiJuCS7t2Yy-I0J-VYKF4PE6SBObuSRTKUZxkWR6N8zhnIY-SLBhj-YOcxxPJVTyBT0Zhxl6R_aqu5BtCYY6QcOycRRmW9kzSlAU8zbF4JXzNHTJs5SGudMkY0XIpVwKlJ1B6YsTgiBwStiITbTI0mG_ZGJ3SiLFoPDESO9hxiG97GndZu8ECkPnbJx5uIcMO0mNYGmrMHHLQQkV0o_CxoPkoDCYOofZnsEW4wBhXst40ImQs4sjkcMhrjbDu3tAbw3Bv_3HQ78ij7sU_IPvr6418T_aabHOoXp2fOE0Pdg |
link.rule.ids | 315,782,786,27933,27934 |
linkProvider | Elsevier |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Improvement+of+Endothelial+Function+With+Dietary+Flavanols+Is+Associated+With+Mobilization+of+Circulating+Angiogenic+Cells+in+Patients+With+Coronary+Artery+Disease&rft.jtitle=Journal+of+the+American+College+of+Cardiology&rft.au=Heiss%2C+Christian&rft.au=Jahn%2C+Sarah&rft.au=Taylor%2C+Melanie&rft.au=Real%2C+Wendy+May&rft.date=2010-07-13&rft.pub=Elsevier+Inc&rft.issn=0735-1097&rft.eissn=1558-3597&rft.volume=56&rft.issue=3&rft.spage=218&rft.epage=224&rft_id=info:doi/10.1016%2Fj.jacc.2010.03.039&rft.externalDocID=S0735109710017365 |
thumbnail_m | http://sdu.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F07351097%2FS0735109710X00250%2Fcov150h.gif |